L
Leslee J. Shaw
Researcher at Cornell University
Publications - 871
Citations - 70793
Leslee J. Shaw is an academic researcher from Cornell University. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 116, co-authored 808 publications receiving 61598 citations. Previous affiliations of Leslee J. Shaw include Saint Louis University & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).
Rory Hachamovitch,Benjamin Nutter,Mark A. Hlatky,Leslee J. Shaw,Michael L. Ridner,Sharmila Dorbala,Rob S. Beanlands,Benjamin J.W. Chow,Elizabeth Branscomb,Panithaya Chareonthaitawee,W. Guy Weigold,Szilard Voros,Suhny Abbara,Tsunehiro Yasuda,Jill E. Jacobs,John R. Lesser,Daniel S. Berman,Louise Thomson,Subha V. Raman,Gary V. Heller,Adam E. Schussheim,Richard C. Brunken,Kim A. Williams,Susan Farkas,Dominique Delbeke,Uwe Joseph Schoepf,Nathaniel Reichek,Stuart Rabinowitz,Steven R. Sigman,Randall Patterson,Carolyn R. Corn,Richard D. White,Ella A. Kazerooni,James R. Corbett,Sabahat Bokhari,Josef Machac,Erminia M. Guarneri,Salvador Borges-Neto,John W. Millstine,James H. Caldwell,James A. Arrighi,Udo Hoffmann,Matthew J. Budoff,Joao A.C. Lima,James R. Johnson,Barbara Johnson,Mariya Gaber,Julie A. Williams,Courtney Foster,Jon Hainer,Marcelo F. Di Carli +50 more
TL;DR: Overall, noninvasive testing had only a modest impact on clinical management of patients referred for clinical testing and post-imaging use of cardiac catheterization and medical therapy increased in proportion to the degree of abnormality findings, suggesting possible undertreatment of higher risk patients.
Journal ArticleDOI
Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography.
Fay Y. Lin,Leslee J. Shaw,Allison Dunning,Troy M. LaBounty,Jin Ho Choi,Jonathan W. Weinsaft,Sunaina Koduru,Millie Gomez,Augustin J. Delago,Tracy Q. Callister,Daniel S. Berman,James K. Min +11 more
TL;DR: In this article, the authors examined mortality risk in relation to extent and composition of nonobstructive plaques by 64-detector row coronary computed tomographic angiography (CCTA).
Journal ArticleDOI
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
G.B. John Mancini,Pamela M. Hartigan,Leslee J. Shaw,Daniel S. Berman,Sean W. Hayes,Eric R. Bates,David J. Maron,Koon K. Teo,Steven P. Sedlis,Bernard R. Chaitman,William S. Weintraub,John A. Spertus,William J. Kostuk,Marcin Dada,David C. Booth,William E. Boden +15 more
TL;DR: In a cohort of patients treated with OMT, anatomic burden was a consistent predictor of death, MI, and NSTE-ACS, whereas ischemic burden was not, and neither determination identified a patient profile benefiting preferentially from an invasive therapeutic strategy.
Journal Article
Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging
Leslee J. Shaw,Robert C. Hendel,Salvador Borges-Neto,Michael S. Lauer,Naomi P. Alazraki,Joy Burnette,Elizabeth G. Krawczynska,Manuel D. Cerqueira,Jamshid Maddahi +8 more
TL;DR: In this article, the authors evaluated the prognostic value of a normal (99m)Tc-tetrofosmin study in a geographically diverse registry of patients undergoing stress myocardial perfusion SPECT.
Journal ArticleDOI
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Janet Wei,Puja K. Mehta,B. Delia Johnson,Bruce Samuels,Saibal Kar,R. David Anderson,Babak Azarbal,John W. Petersen,Barry L. Sharaf,Eileen M. Handberg,Chrisandra Shufelt,Kamlesh Kothawade,George Sopko,Amir Lerman,Leslee J. Shaw,Sheryl F. Kelsey,Carl J. Pepine,C. Noel Bairey Merz +17 more
TL;DR: Results support the use of CRT by experienced operators for establishing definitive diagnosis and assessing prognosis in this at-risk population of symptomatic women and carry a relatively low risk compared with the MACE rate in these women.